Low Energy Proton Beam Induces Efficient Cell Killing in A549 Lung Adenocarcinoma Cells

REFERENCES

• Krengli, M.; Hug, E.B.; Adams, J.A.; Smith, A.R.; Tarbell, N.J.;Munzenrider, J.E. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005, 61, 583–593.
   PubMed Web of Science ®Google Scholar
• St Clair, W.H.; Adams, J.A.; Bues, M.; Fullerton, B.C.; La Shell, S.; Kooy, H.M.; Loeffler, J.S.; Tarbell, N.J. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004, 58, 727–734.
   PubMed Web of Science ®Google Scholar
• Miralbell, R.; Crowell, C.; Suit, H.D. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992, 22, 305–310.
   PubMed Web of Science ®Google Scholar
• Jones, B.; Dale, R.G.; Cárabe-Fernández, A. Charged particle therapy for cancer: the inheritance of the Cavendish scientists? Appl Radiat Isot 2009, 67, 371–377.
   PubMed Web of Science ®Google Scholar
• Chang, J.Y.; Zhang, X.; Wang, X.; Kang, Y.; Riley, B.; Bilton, S.;Mohan, R.; Komaki, R.; Cox, J.D. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 65, 1087–1096.
   PubMed Web of Science ®Google Scholar
• Fukumitsu, N.; Sugahara, S.; Nakayama, H.; Fukuda, K.; Mizumoto, M.; Abei, M.; Shoda, J.; Thono, E.; Tsuboi, K.; Tokuuye, K. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009, 74, 831–836.
   PubMed Web of Science ®Google Scholar
• Shibuya, K.; Mathers, C.D.; Boschi-Pinto, C.; Lopez, A.D.; Murray, C.J. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002, 2, 37.
   Google Scholar
• Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J Clin 2008, 58, 71–96.
   Google Scholar
• Ferlay, J.; Autier, P.; Boniol, M.; Heanue, M.; Colombet, M.; Boyle, P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18, 581–592.
   Google Scholar
• Jassem J. The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol 2007, 83, 203–213.
   PubMed Web of Science ®Google Scholar
• Kim, Y.S.; Yoon, S.M.; Choi, E.K.; Yi, B.Y.; Kim, J.H.; Ahn, S.D.; Lee, S.W.; Shin, S.S.; Lee, J.S.; Suh, C.; Kim, S.W.; Kim, D.S.; Kim, W.S.; Park, H.J.; Park, C.I. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005, 62, 76–81.
   PubMed Web of Science ®Google Scholar
• Farray, D.; Mirkovic, N.; Albain, K.S. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005, 23, 3257–3269.
   PubMed Web of Science ®Google Scholar
• Bush, D.A.; Slater, J.D.; Bonnet, R.; Cheek, G.A.; Dunbar, R.D.; Moyers, M.; Slater, J.M. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999, 116, 1313–1319.
   PubMed Web of Science ®Google Scholar
• Shioyama, Y.; Tokuuye, K.; Okumura, T.; Kagei, K.; Sugahara, S.; Ohara, K.; Akine, Y.; Ishikawa, S.; Satoh, H.; Sekizawa, K. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 56: 7–13.
   PubMed Web of Science ®Google Scholar
• Koto, M.; Miyamoto, T.; Yamamoto, N.; Nishimura, H.; Yamada, S.; Tsujii, H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004, 71, 147–156.
   PubMed Web of Science ®Google Scholar
• Maser, R.S.; Monsen, K.J.; Nelms, B.E.; Petrini, J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol 1997, 17, 6087–6096.
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo, O.; Lee, A.; Nussenzweig, M.; Nussenzweig, A. H2AX: the histone guardian of the genome. DNA Repair 2004, 3, 959–967.
   PubMed Web of Science ®Google Scholar
• Bekker-Jensen, S.; Lukas, C.; Kitagawa, R.; Melander, F.; Kastan, M.B.; Bartek, J.; Lukas, J. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 2006, 173, 195–206.
   PubMed Web of Science ®Google Scholar
• Goto, S.; Watanabe, M.; Yatagai, F. Delayed cell cycle progression in human lymphoblastoid cells after exposure to high-LET radiation correlates with extremely localized DNA damage. Radiat Res 2002, 158, 678–686.
   PubMed Web of Science ®Google Scholar
• Stenerlow, B.; Hoglund, E.; Carlsson, J.; Blomquist, E. Rejoining of DNA fragments produced by radiations of different linear energy transfer. Int J Radiat Biol 2000, 76, 549–557.
   PubMed Web of Science ®Google Scholar
• Lee, K.B.; Lee, J.S.; Park, J.W.; Huh, T.L.; Lee, Y.M. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp Mol Med 2008, 40, 118–129
   PubMed Web of Science ®Google Scholar
• Ghosh, S.; Maurya, D.K.; Krishna, M. Role of iNOS in bystander signaling between macrophages and lymphoma cells. Int J Radiat Oncol Boil Phy 2008, 72, 1567–1574
   PubMed Web of Science ®Google Scholar
• Rasband, W.S. Image, J.U.S. National Institutes of Health, Bethesda, USA, http://rsb.info.nih.gov/ij/ ( 1997–2006).
   Google Scholar
• Khanna, K.K.; Lavin, M.F.; Jackson, S.P.; Mulhern, T.D. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 2001, 8(11), 1052–1065.
   PubMed Web of Science ®Google Scholar
• Lakin, N.D.; Jackson, S.P. Regulation of p53 in response to DNA damage. Oncogene 1999, 18, 7644–7655.
   PubMed Web of Science ®Google Scholar
• Rich, T.; Allen, R.L.; Wyllie, A.H. Defying death after DNA damage. Nature 2000, 407, 777–783.
   PubMed Web of Science ®Google Scholar
• Wang, H.; Zeng, Z.C.; Bui, T.A.; DiBiase, S.J.; Qin, W.; Xia, F.; Powell, S.N.; Iliakis, G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 2001, 61, 270–277
   PubMed Web of Science ®Google Scholar
• Rogakou, E.P.; Pilch, D.R.; Orr, A.H.; Ivanova, V.S.; Bonner, W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998, 273, 5858–5868.
   PubMed Web of Science ®Google Scholar
• Olive, P.L.; Banath, J.P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004, 58, 331–335.
   PubMed Web of Science ®Google Scholar
• Burma, S.; Kurimasa, A.; Xie, G.; Taya, Y.; Araki, R.; Abe, M.; Crissman, H.A.; Ouyang, H.; Li, G.C.; Chen, D.J. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J Biol Chem 1999, 274, 17139–17143.
   PubMed Web of Science ®Google Scholar
• Wang, S.; Guo, M.; Ouyang, H.; Li, X.; Cordon-Cardo, C.; Kurimasa, A.; Chen, D.J.; Fuks, Z.; Ling, C.C.; Li, G.C. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci USA 2000, 97, 1584–1588.
   PubMed Web of Science ®Google Scholar
• Fei, P.; Bernhard, E.J.; El-Deiry, W.S. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002, 62, 7316–7327.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach, E.; Resnitzky, D.; Lotem, J.; Sachs, L.; Kimchi, A.; Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991, 352, 345–347.
   PubMed Web of Science ®Google Scholar
• Sabbatini, P.; Lin, J.; Levine, A.J.; White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995, 9, 2184–2192.
   PubMed Web of Science ®Google Scholar
• Caelles, C.; Helmberg, A.; Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994, 370, 220–223.
   PubMed Web of Science ®Google Scholar
• Polyak, K.; Xia, Y.; Zweier, J.L.; Kinzler, K.W.; Vogelstein, B. A model for p53-induced apoptosis. Nature 1997, 389, 300–305.
   PubMed Web of Science ®Google Scholar
• Mihara, M.; Erster, S.; Zaika, A.; Petrenko, O.; Chittenden, T.; Pancoska, P.; Moll, U.M. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003, 11, 577–590.
   PubMed Web of Science ®Google Scholar
• Fei, P.; El-Deiry, W.S. p53 and radiation responses. Oncogene 2003, 22, 5774–5783.
   PubMed Web of Science ®Google Scholar
• Mitra, A.K.; Bhat, N.; Sarma, A.; Krishna, M. Alteration in the expression of signaling parameters following carbon ion irradiation. Mol Cell Biochem 2005, 276(1–2), 169–173.
   PubMed Web of Science ®Google Scholar